Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HEMOCUE HEMOGLOBIN 201 + SYSTEM ARTICLE 121704

K-Number: K032203 · 2003-08-25

ApplicantHemocue, Inc.
Decision Date2003-08-25
Product CodeGKR
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

HEMOCUE HEMOGLOBIN 201 + SYSTEM ARTICLE 121704 is the device name listed in this FDA 510(k) record. The listed applicant is Hemocue, Inc.. It received FDA 510(k) clearance on 2003-08-25 under 510(k) number K032203. The device is classified under product code GKR. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HEMOCUE HEMOGLOBIN 201 + SYSTEM ARTICLE 121704?

HEMOCUE HEMOGLOBIN 201 + SYSTEM ARTICLE 121704 is a medical device that received FDA 510(k) clearance on 2003-08-25. The listed applicant is Hemocue, Inc.. The 510(k) number is K032203.

When did HEMOCUE HEMOGLOBIN 201 + SYSTEM ARTICLE 121704 receive FDA 510(k) clearance?

HEMOCUE HEMOGLOBIN 201 + SYSTEM ARTICLE 121704 received FDA 510(k) clearance on 2003-08-25, under 510(k) number K032203.

Who is the listed applicant for HEMOCUE HEMOGLOBIN 201 + SYSTEM ARTICLE 121704?

The FDA 510(k) record lists Hemocue, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HEMOCUE HEMOGLOBIN 201 + SYSTEM ARTICLE 121704?

The FDA product code for HEMOCUE HEMOGLOBIN 201 + SYSTEM ARTICLE 121704 is GKR.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Hemocue, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K041234HEMOCUE HEMOGLOBIN 201DM ANALYZING SYSTEMK041230CLINICAL LABORATORY ANALYZING SYSTEMK020935HEMOCUE GLUCOSE 201 SYSTEM, ARTICLE NUMBER 120706K962415HEMOCUE B-GLCOSE SYSTEMK961312HEMOCUE B-HEMOGLOBIN SYSTEMK961311HEMOCUE B-GLUCOSE SYSTEM

View all 9 devices →

Related Devices (Code: GKR)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K201217HemoCue Hb 301 SystemHemocue ABK200909Hemo Control (optional Add Pack Hemo Control DM)Ekf-Diagnostic GmbHK181751HemoCue Hb 801 SystemHemocue ABK182298hemochroma PLUS SystemImmunostics Inc.,K172173DiaSpect Tm, DiaSpect Tm CuvettesEkf-Diagnostic GmbHK163465hemochroma PLUS SystemImmunostics Inc.,

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑